Tapewire

Nasdaq · USD

ELOX

Eloxx Pharmaceuticals, Inc.

Export transactions ↓
Tapewire entity
7180
SEC CIK
0001035354
Parsed reports
201

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 10, 2026 Filed Jun 11, 2026 00:00 UTC
Aggarwal SumitDirector · President and CEO
GrantStock Option (Right to Buy) · Derivative 328,833 $0.00 Strike: $1.65 $0.00
Disclosure

SEC source: 0001193125-26-266277 · ownership.xml · derivative · entry 1

Aggarwal Sumit · CIK 0001854362 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 328,833

Underlying: Common Stock · 328,833 shares

Expires 2035-09-19

F1 · derivative.exercise_date: The option was granted on September 19, 2025 and was subject to a performance-based vesting condition that was satisfied on June 10, 2026. The option will vest as to 1/36 on July 31, 2026, with the remaining options vesting in equal consecutive monthly increments for 35 months, subject to the Reporting Person's continuing service on each such vesting date.

Read SEC document
June 10, 2026 Filed Jun 17, 2026 21:15 UTC OtherPre-funded Warrant · Derivative 361,578 Not disclosed Not disclosed
Disclosure

SEC source: 0000919574-26-004021 · ownership.xml · derivative · entry 5

Domicilium Real Estate Fund III LP · CIK 0001945896 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 834,489

Underlying: common stock, $0.01 par value per share · 361,578 shares

Expires not disclosed

F5 · derivative.exercise_price: The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 19.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise.

F1 · kind: Each pre-funded warrant to purchase shares of the Issuer's common stock (the "Pre-Funded Warrants") was exchanged (pursuant to the terms of the Pre-Funded Warrant) for 1 share of the Issuer's common stock.

F5 · price: The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 19.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise.

F5 · derivative.exercise_date: The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 19.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise.

F5 · derivative.expiration_date: The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 19.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise.

F3 · ownership.nature: The securities are owned directly by BKJLAGG, LLC ("BKJLAGG") and may be deemed to be indirectly beneficially owned by (i) Domicilium, the investment adviser to BKJLAGG, and (ii) Daniel Simon, the managing member of Domicilium.

Read SEC document
June 10, 2026 Filed Jun 17, 2026 21:15 UTC OtherPre-funded Warrant · Derivative 238,422 Not disclosed Not disclosed
Disclosure

SEC source: 0000919574-26-004021 · ownership.xml · derivative · entry 4

Domicilium Real Estate Fund III LP · CIK 0001945896 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: common stock, $0.01 par value per share · 238,422 shares

Expires not disclosed

F5 · derivative.exercise_price: The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 19.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise.

F1 · kind: Each pre-funded warrant to purchase shares of the Issuer's common stock (the "Pre-Funded Warrants") was exchanged (pursuant to the terms of the Pre-Funded Warrant) for 1 share of the Issuer's common stock.

F5 · price: The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 19.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise.

F5 · derivative.exercise_date: The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 19.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise.

F5 · derivative.expiration_date: The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 19.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise.

F2 · ownership.nature: The securities are owned directly by Domicilium Real Estate Fund III LP (the "Fund") and may be deemed to be indirectly beneficially owned by (i) Domicilium Capital Partners LLC, ("Domicilium"), the investment adviser to the Fund, (ii) Domicilium Real Estate Fund III GP LLC (the "General Partner"), the general partner of the Fund, and (ii) Daniel Simon, the managing member of Domicilium and the General Partner.

Read SEC document
June 10, 2026 Filed Jun 17, 2026 21:15 UTC Othercommon stock, $0.01 par value per share 361,578 Not disclosed Not disclosed
Disclosure

SEC source: 0000919574-26-004021 · ownership.xml · nonDerivative · entry 2

Domicilium Real Estate Fund III LP · CIK 0001945896 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 361,578

F1 · kind: Each pre-funded warrant to purchase shares of the Issuer's common stock (the "Pre-Funded Warrants") was exchanged (pursuant to the terms of the Pre-Funded Warrant) for 1 share of the Issuer's common stock.

F1 · price: Each pre-funded warrant to purchase shares of the Issuer's common stock (the "Pre-Funded Warrants") was exchanged (pursuant to the terms of the Pre-Funded Warrant) for 1 share of the Issuer's common stock.

F3 · ownership.nature: The securities are owned directly by BKJLAGG, LLC ("BKJLAGG") and may be deemed to be indirectly beneficially owned by (i) Domicilium, the investment adviser to BKJLAGG, and (ii) Daniel Simon, the managing member of Domicilium.

Read SEC document
June 10, 2026 Filed Jun 17, 2026 21:15 UTC Othercommon stock, $0.01 par value per share 238,422 Not disclosed Not disclosed
Disclosure

SEC source: 0000919574-26-004021 · ownership.xml · nonDerivative · entry 1

Domicilium Real Estate Fund III LP · CIK 0001945896 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 238,422

F1 · kind: Each pre-funded warrant to purchase shares of the Issuer's common stock (the "Pre-Funded Warrants") was exchanged (pursuant to the terms of the Pre-Funded Warrant) for 1 share of the Issuer's common stock.

F1 · price: Each pre-funded warrant to purchase shares of the Issuer's common stock (the "Pre-Funded Warrants") was exchanged (pursuant to the terms of the Pre-Funded Warrant) for 1 share of the Issuer's common stock.

F2 · ownership.nature: The securities are owned directly by Domicilium Real Estate Fund III LP (the "Fund") and may be deemed to be indirectly beneficially owned by (i) Domicilium Capital Partners LLC, ("Domicilium"), the investment adviser to the Fund, (ii) Domicilium Real Estate Fund III GP LLC (the "General Partner"), the general partner of the Fund, and (ii) Daniel Simon, the managing member of Domicilium and the General Partner.

Read SEC document
June 08, 2026 Filed Jun 11, 2026 00:00 UTC GrantStock Option (Right to Buy) · Derivative 13,587 $0.00 Strike: $11.00 $0.00
Disclosure

SEC source: 0001193125-26-266279 · ownership.xml · derivative · entry 1

Webster Stephen W · CIK 0001438421 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,587

Underlying: Common Stock · 13,587 shares

Expires 2036-06-08

F1 · derivative.exercise_date: The stock option will vest in 24 substantially equal monthly installments so that the option will be fully vested and exercisable on the second anniversary of the grant date, subject to the Reporting Person's continuous service to the Issuer through the applicable vesting date.

Read SEC document
June 08, 2026 Filed Jun 11, 2026 00:00 UTC GrantStock Option (Right to Buy) · Derivative 8,590 $0.00 Strike: $11.00 $0.00
Disclosure

SEC source: 0001193125-26-266278 · ownership.xml · derivative · entry 1

Walts Alan Edmund · CIK 0001853544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,590

Underlying: Common Stock · 8,590 shares

Expires 2036-06-08

F1 · derivative.exercise_date: The stock option will vest in 24 substantially equal monthly installments so that the option will be fully vested and exercisable on the second anniversary of the grant date, subject to the Reporting Person's continuous service to the Issuer through the applicable vesting date.

Read SEC document
June 08, 2026 Filed Jun 11, 2026 00:00 UTC GrantStock Option (Right to Buy) · Derivative 13,587 $0.00 Strike: $11.00 $0.00
Disclosure

SEC source: 0001193125-26-266276 · ownership.xml · derivative · entry 1

Kjellson Nina S · CIK 0001381980 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,587

Underlying: Common Stock · 13,587 shares

Expires 2036-06-08

F1 · derivative.exercise_date: The stock option will vest in 24 substantially equal monthly installments so that the option will be fully vested and exercisable on the second anniversary of the grant date, subject to the Reporting Person's continuous service to the Issuer through the applicable vesting date.

Read SEC document
June 08, 2026 Filed Jun 11, 2026 00:00 UTC GrantStock Option (Right to Buy) · Derivative 4,018 $0.00 Strike: $11.00 $0.00
Disclosure

SEC source: 0001193125-26-266275 · ownership.xml · derivative · entry 1

Rubin Steven D · CIK 0001381874 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,018

Underlying: Common Stock · 4,018 shares

Expires 2036-06-08

F1 · derivative.exercise_date: The stock option will vest in 24 substantially equal monthly installments so that the option will be fully vested and exercisable on the second anniversary of the grant date, subject to the Reporting Person's continuous service to the Issuer through the applicable vesting date.

Read SEC document
May 27, 2026 Filed May 30, 2026 01:55 UTC OtherPre-funded Warrant · Derivative 1,250,000 $0.00 Strike: $0.01 $0.00
Disclosure

SEC source: 0001104659-26-068440 · tm2615865-2_4seq1.xml · derivative · entry 2

Coastlands Capital LP · CIK 0002068530 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Coastlands Capital LP

Disclosed balance after: 30,612,243

Underlying: Common Stock · 1,250,000 shares

Expires not disclosed

F1 · kind: Pursuant to the terms of that certain Amended and Restated Pre-Funded Warrant to Purchase Common Stock, dated as of April 27, 2026, Coastlands Capital Partners LP (the "Partnership"), exchanged 1,250,000 shares of common stock of the Issuer for pre-funded warrants to purchase an equivalent number of shares of common stock of the Issuer.

F3 · derivative.exercise_date: The pre-funded warrants to purchase shares of the Issuer's common stock (the "Pre-Funded Warrants") have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise.

F3 · derivative.expiration_date: The pre-funded warrants to purchase shares of the Issuer's common stock (the "Pre-Funded Warrants") have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise.

F2 · ownership.nature: Coastlands Capital LP ("Coastlands") and Coastlands Capital GP LLC (the "General Partner") are the investment adviser and general partner, respectively, of the Partnership. Coastlands Capital LLC ("Coastlands GP") is the general partner of Coastlands. Matthew Perry is the control person of Coastlands, the Partnership, Coastlands GP and the General Partner. The reporting persons are filing this Form 4 jointly, but not as members of a group, and each disclaims membership in a group. Each reporting person also disclaims beneficial ownership of common stock except to the extent of that person's pecuniary interest therein.

Read SEC document
May 27, 2026 Filed May 30, 2026 01:55 UTC OtherCommon Stock 1,250,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-068440 · tm2615865-2_4seq1.xml · nonDerivative · entry 1

Coastlands Capital LP · CIK 0002068530 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Coastlands Capital LP

Disclosed balance after: 0

F1 · kind: Pursuant to the terms of that certain Amended and Restated Pre-Funded Warrant to Purchase Common Stock, dated as of April 27, 2026, Coastlands Capital Partners LP (the "Partnership"), exchanged 1,250,000 shares of common stock of the Issuer for pre-funded warrants to purchase an equivalent number of shares of common stock of the Issuer.

F2 · ownership.nature: Coastlands Capital LP ("Coastlands") and Coastlands Capital GP LLC (the "General Partner") are the investment adviser and general partner, respectively, of the Partnership. Coastlands Capital LLC ("Coastlands GP") is the general partner of Coastlands. Matthew Perry is the control person of Coastlands, the Partnership, Coastlands GP and the General Partner. The reporting persons are filing this Form 4 jointly, but not as members of a group, and each disclaims membership in a group. Each reporting person also disclaims beneficial ownership of common stock except to the extent of that person's pecuniary interest therein.

Read SEC document
May 27, 2026 Filed Jun 5, 2026 14:44 UTC OtherPre-funded Warrant · Derivative 113,636 Not disclosed Not disclosed
Disclosure

SEC source: 0000919574-26-003845 · ownership.xml · derivative · entry 3

Domicilium Real Estate Fund III LP · CIK 0001945896 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 238,422

Underlying: Common Stock, $0.01 par value per share · 113,636 shares

Expires not disclosed

F5 · derivative.exercise_price: The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise.

F1 · kind: Pursuant to the terms of the pre-funded warrants to purchase shares of the Issuer's common stock (the "Pre-Funded Warrants"), Domicilium Real Estate Fund III LP (the "Fund"), exchanged 1,250,000 shares of common stock of the Issuer for pre-funded warrants to purchase an equivalent number of shares of common stock of the Issuer.

F2 · shares: These securities reflect a 11 for 1 reverse stock split effective May 29, 2026.

F5 · price: The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise.

F5 · derivative.exercise_date: The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise.

F5 · derivative.expiration_date: The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise.

F2 · derivative.underlying_shares: These securities reflect a 11 for 1 reverse stock split effective May 29, 2026.

F2 · balance_after: These securities reflect a 11 for 1 reverse stock split effective May 29, 2026.

F3 · ownership.direct: The securities are owned directly by the Fund and may be deemed to be indirectly beneficially owned by (i) Domicilium Capital Partners LLC, ("Domicilium") the investment adviser to the Fund, (ii) Domicilium Real Estate Fund III GP LLC (the "General Partner"), the general partner of the Fund, and (iii) Daniel Simon, the managing member of Domicilium and the General Partner.

Read SEC document
May 27, 2026 Filed Jun 5, 2026 14:44 UTC OtherCommon Stock, $0.01 par value per share 113,636 $0.00 $0.00
Disclosure

SEC source: 0000919574-26-003845 · ownership.xml · nonDerivative · entry 1

Domicilium Real Estate Fund III LP · CIK 0001945896 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · kind: Pursuant to the terms of the pre-funded warrants to purchase shares of the Issuer's common stock (the "Pre-Funded Warrants"), Domicilium Real Estate Fund III LP (the "Fund"), exchanged 1,250,000 shares of common stock of the Issuer for pre-funded warrants to purchase an equivalent number of shares of common stock of the Issuer.

F2 · shares: These securities reflect a 11 for 1 reverse stock split effective May 29, 2026.

F3 · ownership.direct: The securities are owned directly by the Fund and may be deemed to be indirectly beneficially owned by (i) Domicilium Capital Partners LLC, ("Domicilium") the investment adviser to the Fund, (ii) Domicilium Real Estate Fund III GP LLC (the "General Partner"), the general partner of the Fund, and (iii) Daniel Simon, the managing member of Domicilium and the General Partner.

Read SEC document
February 28, 2026 Filed May 8, 2026 20:53 UTC
Aggarwal SumitDirector · President and CEO · 10% owner
Exercise / conversionStock Option (Right to Buy) · Derivative 260,946 $0.00 Strike: $0.15 $0.00
Disclosure

SEC source: 0001193125-26-214890 · ownership.xml · derivative · entry 20

Aggarwal Sumit · CIK 0001854362 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,336,144

Underlying: Common Stock · 260,946 shares

Expires 2035-09-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F12 · derivative.exercise_date: The option vests as follows: (i) as to 1,736,275 shares, vested 1/36 on October 31, 2025, with the remaining options vesting thereafter in equal consecutive monthly increments over 35 months; (ii) as to 612,245 shares, vested 1/36 on January 31, 2026, with the remaining options vesting thereafter in equal consecutive monthly increments over 35 months; and (iii) as to 1,248,570 shares, vested 1/36 on March 31, 2026, with the remaining options vesting thereafter in equal consecutive monthly increments over 35 months, subject to the Reporting Person's continuous service to the Issuer through the applicable vesting date.

Read SEC document
February 28, 2026 Filed May 8, 2026 20:53 UTC
Aggarwal SumitDirector · President and CEO · 10% owner
Exercise / conversionCommon Stock 260,946 $0.15 $39,141.90
Disclosure

SEC source: 0001193125-26-214890 · ownership.xml · nonDerivative · entry 4

Aggarwal Sumit · CIK 0001854362 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,672,756

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 24, 2026 Filed May 8, 2026 20:53 UTC
Aggarwal SumitDirector · President and CEO · 10% owner
Exercise / conversionRestricted Stock Units · Derivative 15,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-214890 · ownership.xml · derivative · entry 19

Aggarwal Sumit · CIK 0001854362 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

F13 · derivative.exercise_date: The RSUs vested as to 50% on the first anniversary of January 24, 2024 and the remaining amount vested in two equal annual installments thereafter.

F13 · derivative.expiration_date: The RSUs vested as to 50% on the first anniversary of January 24, 2024 and the remaining amount vested in two equal annual installments thereafter.

Read SEC document
January 24, 2026 Filed May 8, 2026 20:53 UTC
Aggarwal SumitDirector · President and CEO · 10% owner
Exercise / conversionCommon Stock 15,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-214890 · ownership.xml · nonDerivative · entry 3

Aggarwal Sumit · CIK 0001854362 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,411,810

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 24, 2026 Filed May 8, 2026 21:12 UTC Exercise / conversionRestricted Stock Units · Derivative 1,875 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-214983 · ownership.xml · derivative · entry 3

Rubin Steven D · CIK 0001381874 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,875

Underlying: Common Stock · 1,875 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: The RSUs vested as to 50% on the first anniversary of January 24, 2024 and the remaining amount vested in two equal annual installments thereafter.

F3 · derivative.expiration_date: The RSUs vested as to 50% on the first anniversary of January 24, 2024 and the remaining amount vested in two equal annual installments thereafter.

Read SEC document
January 24, 2026 Filed May 8, 2026 21:12 UTC Exercise / conversionCommon Stock 1,875 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-214983 · ownership.xml · nonDerivative · entry 1

Rubin Steven D · CIK 0001381874 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,625

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 24, 2026 Filed May 8, 2026 20:44 UTC Exercise / conversionRestricted Stock Units · Derivative 1,875 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-214815 · ownership.xml · derivative · entry 3

Walts Alan Edmund · CIK 0001853544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,875

Underlying: Common Stock · 1,875 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: The RSUs vested as to 50% on the first anniversary of January 24, 2024, and the remaining amount vested in two equal annual installments thereafter.

F3 · derivative.expiration_date: The RSUs vested as to 50% on the first anniversary of January 24, 2024, and the remaining amount vested in two equal annual installments thereafter.

Read SEC document
January 24, 2026 Filed May 8, 2026 20:44 UTC Exercise / conversionCommon Stock 1,875 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-214815 · ownership.xml · nonDerivative · entry 1

Walts Alan Edmund · CIK 0001853544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,567

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
September 19, 2025 Filed May 8, 2026 20:53 UTC
Aggarwal SumitDirector · President and CEO · 10% owner
GrantStock Option (Right to Buy) · Derivative 3,597,090 $0.00 Strike: $0.15 $0.00
Disclosure

SEC source: 0001193125-26-214890 · ownership.xml · derivative · entry 18

Aggarwal Sumit · CIK 0001854362 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,597,090

Underlying: Common Stock · 3,597,090 shares

Expires 2035-09-19

F12 · derivative.exercise_date: The option vests as follows: (i) as to 1,736,275 shares, vested 1/36 on October 31, 2025, with the remaining options vesting thereafter in equal consecutive monthly increments over 35 months; (ii) as to 612,245 shares, vested 1/36 on January 31, 2026, with the remaining options vesting thereafter in equal consecutive monthly increments over 35 months; and (iii) as to 1,248,570 shares, vested 1/36 on March 31, 2026, with the remaining options vesting thereafter in equal consecutive monthly increments over 35 months, subject to the Reporting Person's continuous service to the Issuer through the applicable vesting date.

Read SEC document
September 19, 2025 Filed May 8, 2026 20:53 UTC
Aggarwal SumitDirector · President and CEO · 10% owner
GrantCommon Stock 1,000,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-214890 · ownership.xml · nonDerivative · entry 2

Aggarwal Sumit · CIK 0001854362 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,396,810

F1 · shares: Represents a grant of restricted stock units ("RSUs") that was fully vested upon grant.

Read SEC document
September 19, 2025 Filed May 8, 2026 21:12 UTC GrantStock Option (Right to Buy) · Derivative 179,854 $0.00 Strike: $0.15 $0.00
Disclosure

SEC source: 0001193125-26-214983 · ownership.xml · derivative · entry 2

Rubin Steven D · CIK 0001381874 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 179,854

Underlying: Common Stock · 179,854 shares

Expires 2035-09-19

F2 · derivative.exercise_date: The stock option vested as to 1/36 on October 31, 2025, with the remaining options vesting thereafter in equal consecutive monthly increments for 35 months, subject to the Reporting Person's continuous service to the Issuer through the applicable vesting date.

Read SEC document
September 19, 2025 Filed May 8, 2026 20:44 UTC GrantStock Option (Right to Buy) · Derivative 395,680 $0.00 Strike: $0.15 $0.00
Disclosure

SEC source: 0001193125-26-214815 · ownership.xml · derivative · entry 2

Walts Alan Edmund · CIK 0001853544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 395,680

Underlying: Common Stock · 395,680 shares

Expires 2035-09-19

F2 · derivative.exercise_date: The stock option vested as to 1/36 on October 31, 2025, with the remaining options vesting thereafter in equal consecutive monthly increments for 35 months, subject to the Reporting Person's continuous service to the Issuer through the applicable vesting date.

Read SEC document
August 14, 2025 Filed May 8, 2026 20:53 UTC
Aggarwal SumitDirector · President and CEO · 10% owner
Exercise / conversionStock Option (Right to Buy) · Derivative 42,790 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001193125-26-214890 · ownership.xml · derivative · entry 17

Aggarwal Sumit · CIK 0001854362 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 42,790 shares

Expires 2032-02-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock option vested and became exercisable over the four-year period commencing February 6, 2022, with one-fourth of the shares of common stock underlying the options vesting on February 6, 2023, and the remainder vesting in twelve equal quarterly installments thereafter. The Board accelerated vesting on the unvested portion in connection with the exercise.

Read SEC document
August 14, 2025 Filed May 8, 2026 20:53 UTC
Aggarwal SumitDirector · President and CEO · 10% owner
Exercise / conversionStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001193125-26-214890 · ownership.xml · derivative · entry 16

Aggarwal Sumit · CIK 0001854362 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2033-08-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F11 · derivative.exercise_date: The option was granted on August 23, 2023 and was scheduled to vest subject to certain performance criteria, which the Board waived in connection with the exercise.

Read SEC document
August 14, 2025 Filed May 8, 2026 20:53 UTC
Aggarwal SumitDirector · President and CEO · 10% owner
Exercise / conversionStock Option (Right to Buy) · Derivative 68,700 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001193125-26-214890 · ownership.xml · derivative · entry 15

Aggarwal Sumit · CIK 0001854362 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 68,700 shares

Expires 2033-01-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_date: The option vested and became exercisable as to 25% of the underlying shares on the first anniversary of January 25, 2023, and the remaining 75% of the underlying shares vested in 12 equal quarterly installments thereafter. The Board accelerated vesting on the unvested portion in connection with the exercise.

Read SEC document
August 14, 2025 Filed May 8, 2026 20:53 UTC
Aggarwal SumitDirector · President and CEO · 10% owner
Exercise / conversionStock Option (Right to Buy) · Derivative 60,390 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001193125-26-214890 · ownership.xml · derivative · entry 14

Aggarwal Sumit · CIK 0001854362 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 60,390 shares

Expires 2031-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The stock option vested and became exercisable over the four-year period commencing April 1, 2021, with one-fourth of the shares of common stock underlying the options vesting on April 1, 2022, and the remainder vesting in twelve equal quarterly installments thereafter.

Read SEC document
August 14, 2025 Filed May 8, 2026 20:53 UTC
Aggarwal SumitDirector · President and CEO · 10% owner
Exercise / conversionCommon Stock 196,880 $0.00 $19.69
Disclosure

SEC source: 0001193125-26-214890 · ownership.xml · nonDerivative · entry 1

Aggarwal Sumit · CIK 0001854362 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 396,810

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 24, 2025 Filed Jan 28, 2025 22:37 UTC Exercise / conversionRestricted Stock Units · Derivative 30,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-006784 · tm254730-4_4seq1.xml · derivative · entry 2

Aggarwal Sumit · CIK 0001854362 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_price: The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date.

F2 · price: The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date.

F2 · derivative.exercise_date: The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date.

F2 · derivative.expiration_date: The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date.

Read SEC document
January 24, 2025 Filed Jan 28, 2025 22:37 UTC Exercise / conversionCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-006784 · tm254730-4_4seq1.xml · nonDerivative · entry 1

Aggarwal Sumit · CIK 0001854362 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 199,930

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 24, 2025 Filed Jan 28, 2025 22:36 UTC Exercise / conversionRestricted Stock Units · Derivative 3,750 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-006783 · tm254730-3_4seq1.xml · derivative · entry 2

Rubin Steven D · CIK 0001381874 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,750

Underlying: Common Stock · 3,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_price: The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date.

F2 · price: The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date.

F2 · derivative.exercise_date: The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date.

F2 · derivative.expiration_date: The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date.

Read SEC document
January 24, 2025 Filed Jan 28, 2025 22:36 UTC Exercise / conversionCommon Stock 3,750 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-006783 · tm254730-3_4seq1.xml · nonDerivative · entry 1

Rubin Steven D · CIK 0001381874 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,750

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 24, 2025 Filed Jan 28, 2025 22:35 UTC Exercise / conversionRestricted Stock Units · Derivative 3,750 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-006782 · tm254730-2_4seq1.xml · derivative · entry 2

Androski Lindsay · CIK 0001936604 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,750

Underlying: Common Stock · 3,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_price: The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date.

F2 · derivative.expiration_date: The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date.

F2 · balance_after: The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date.

Read SEC document
January 24, 2025 Filed Jan 28, 2025 22:35 UTC Exercise / conversionCommon Stock 3,750 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-006782 · tm254730-2_4seq1.xml · nonDerivative · entry 1

Androski Lindsay · CIK 0001936604 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,750

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 24, 2025 Filed Jan 28, 2025 22:34 UTC Exercise / conversionRestricted Stock Units · Derivative 3,750 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-006781 · tm254730-1_4seq1.xml · derivative · entry 2

Walts Alan Edmund · CIK 0001853544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,750

Underlying: Common Stock · 3,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_price: The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date.

F2 · price: The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date.

F2 · derivative.exercise_date: The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date.

F2 · derivative.expiration_date: The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date.

Read SEC document
January 24, 2025 Filed Jan 28, 2025 22:34 UTC Exercise / conversionCommon Stock 3,750 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-006781 · tm254730-1_4seq1.xml · nonDerivative · entry 1

Walts Alan Edmund · CIK 0001853544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,692

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 16, 2024 Filed Oct 17, 2024 20:02 UTC GrantCommon Stock 12,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-109525 · tm2426349-5_4seq1.xml · nonDerivative · entry 1

Walts Alan Edmund · CIK 0001853544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,942

F1 · kind: This restricted stock grant was made pursuant to the Issuer's 2018 Equity Incentive Plan and vests as to 50% of the shares on October 16, 2025 and in 12 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.

Read SEC document
October 16, 2024 Filed Oct 17, 2024 20:01 UTC GrantCommon Stock 12,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-109524 · tm2426349-4_4seq1.xml · nonDerivative · entry 1

Androski Lindsay · CIK 0001936604 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,000

F1 · kind: This restricted stock grant was made pursuant to the Issuer's 2018 Equity Incentive Plan and vests as to 50% of the shares on October 16, 2025 and in 12 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

Read SEC document
October 16, 2024 Filed Oct 17, 2024 20:01 UTC GrantCommon Stock 12,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-109523 · tm2426349-3_4seq1.xml · nonDerivative · entry 1

Rubin Steven D · CIK 0001381874 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,000

F1 · kind: This restricted stock grant was made pursuant to the Issuer's 2018 Equity Incentive Plan and vests as to 50% of the shares on October 16, 2025 and in 12 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

Read SEC document
October 16, 2024 Filed Oct 17, 2024 20:01 UTC
Aggarwal SumitDirector · PRESIDENT AND CEO
GrantCommon Stock 165,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-109519 · tm2426349-2_4seq1.xml · nonDerivative · entry 1

Aggarwal Sumit · CIK 0001854362 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 169,930

F1 · shares: This restricted stock award was made under the Issuer's 2018 Equity Incentive Plan and vests as to 25% on October 16, 2025 and in 12 substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date.

Read SEC document
October 16, 2024 Filed May 8, 2026 20:53 UTC
Aggarwal SumitDirector · President and CEO · 10% owner
GrantStock Option (Right to Buy) · Derivative 68,700 Not disclosed Strike: $0.00 Not disclosed
Disclosure

SEC source: 0001193125-26-214890 · ownership.xml · derivative · entry 13

Aggarwal Sumit · CIK 0001854362 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,700

Underlying: Common Stock · 68,700 shares

Expires 2033-01-25

F10 · price: The reporting person agreed to cancellation of an option granted to him on January 25, 2023 in exchange for a new option having a lower exercise price.

F9 · derivative.exercise_date: The option vested and became exercisable as to 25% of the underlying shares on the first anniversary of January 25, 2023, and the remaining 75% of the underlying shares vested in 12 equal quarterly installments thereafter. The Board accelerated vesting on the unvested portion in connection with the exercise.

Read SEC document
October 16, 2024 Filed May 8, 2026 20:53 UTC
Aggarwal SumitDirector · President and CEO · 10% owner
Disposition to issuerStock Option (Right to Buy) · Derivative 68,700 Not disclosed Strike: $4.27 Not disclosed
Disclosure

SEC source: 0001193125-26-214890 · ownership.xml · derivative · entry 12

Aggarwal Sumit · CIK 0001854362 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 68,700 shares

Expires 2033-01-25

F10 · price: The reporting person agreed to cancellation of an option granted to him on January 25, 2023 in exchange for a new option having a lower exercise price.

F9 · derivative.exercise_date: The option vested and became exercisable as to 25% of the underlying shares on the first anniversary of January 25, 2023, and the remaining 75% of the underlying shares vested in 12 equal quarterly installments thereafter. The Board accelerated vesting on the unvested portion in connection with the exercise.

Read SEC document
October 16, 2024 Filed May 8, 2026 20:53 UTC
Aggarwal SumitDirector · President and CEO · 10% owner
GrantStock Option (Right to Buy) · Derivative 24,810 Not disclosed Strike: $0.00 Not disclosed
Disclosure

SEC source: 0001193125-26-214890 · ownership.xml · derivative · entry 11

Aggarwal Sumit · CIK 0001854362 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,810

Underlying: Common Stock · 24,810 shares

Expires 2031-04-01

F8 · price: The reporting person agreed to cancellation of an option granted to him on May 18, 2021 in exchange for a new option having a lower exercise price.

F6 · derivative.exercise_date: The stock option vested and became exercisable over the four-year period commencing April 1, 2021, with one-fourth of the shares of common stock underlying the options vesting on April 1, 2022, and the remainder vesting in twelve equal quarterly installments thereafter.

Read SEC document
October 16, 2024 Filed May 8, 2026 20:53 UTC
Aggarwal SumitDirector · President and CEO · 10% owner
Disposition to issuerStock Option (Right to Buy) · Derivative 24,810 Not disclosed Strike: $1.41 Not disclosed
Disclosure

SEC source: 0001193125-26-214890 · ownership.xml · derivative · entry 10

Aggarwal Sumit · CIK 0001854362 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 24,810 shares

Expires 2031-04-01

F4 · shares: On December 1, 2022, the Issuer effected a 1-for-40 reverse stock split. The share count has been adjusted to reflect the reverse stock split.

F8 · price: The reporting person agreed to cancellation of an option granted to him on May 18, 2021 in exchange for a new option having a lower exercise price.

F6 · derivative.exercise_date: The stock option vested and became exercisable over the four-year period commencing April 1, 2021, with one-fourth of the shares of common stock underlying the options vesting on April 1, 2022, and the remainder vesting in twelve equal quarterly installments thereafter.

Read SEC document
October 16, 2024 Filed May 8, 2026 20:53 UTC
Aggarwal SumitDirector · President and CEO · 10% owner
GrantStock Option (Right to Buy) · Derivative 35,580 Not disclosed Strike: $0.00 Not disclosed
Disclosure

SEC source: 0001193125-26-214890 · ownership.xml · derivative · entry 9

Aggarwal Sumit · CIK 0001854362 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,580

Underlying: Common Stock · 35,580 shares

Expires 2031-04-01

F7 · price: The reporting person agreed to cancellation of an option granted to him on April 1, 2021 in exchange for a new option having a lower exercise price.

F6 · derivative.exercise_date: The stock option vested and became exercisable over the four-year period commencing April 1, 2021, with one-fourth of the shares of common stock underlying the options vesting on April 1, 2022, and the remainder vesting in twelve equal quarterly installments thereafter.

Read SEC document
October 16, 2024 Filed May 8, 2026 20:53 UTC
Aggarwal SumitDirector · President and CEO · 10% owner
Disposition to issuerStock Option (Right to Buy) · Derivative 35,580 Not disclosed Strike: $3.36 Not disclosed
Disclosure

SEC source: 0001193125-26-214890 · ownership.xml · derivative · entry 8

Aggarwal Sumit · CIK 0001854362 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 35,580 shares

Expires 2031-04-01

F4 · shares: On December 1, 2022, the Issuer effected a 1-for-40 reverse stock split. The share count has been adjusted to reflect the reverse stock split.

F7 · price: The reporting person agreed to cancellation of an option granted to him on April 1, 2021 in exchange for a new option having a lower exercise price.

F6 · derivative.exercise_date: The stock option vested and became exercisable over the four-year period commencing April 1, 2021, with one-fourth of the shares of common stock underlying the options vesting on April 1, 2022, and the remainder vesting in twelve equal quarterly installments thereafter.

Read SEC document
October 16, 2024 Filed May 8, 2026 20:53 UTC
Aggarwal SumitDirector · President and CEO · 10% owner
GrantStock Option (Right to Buy) · Derivative 42,790 Not disclosed Strike: $0.00 Not disclosed
Disclosure

SEC source: 0001193125-26-214890 · ownership.xml · derivative · entry 7

Aggarwal Sumit · CIK 0001854362 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,790

Underlying: Common Stock · 42,790 shares

Expires 2032-02-06

F5 · price: The reporting person agreed to cancellation of an option granted to him on February 6, 2022 in exchange for a new option having a lower exercise price.

F3 · derivative.exercise_date: The stock option vested and became exercisable over the four-year period commencing February 6, 2022, with one-fourth of the shares of common stock underlying the options vesting on February 6, 2023, and the remainder vesting in twelve equal quarterly installments thereafter. The Board accelerated vesting on the unvested portion in connection with the exercise.

Read SEC document
October 16, 2024 Filed May 8, 2026 20:53 UTC
Aggarwal SumitDirector · President and CEO · 10% owner
Disposition to issuerStock Option (Right to Buy) · Derivative 42,790 Not disclosed Strike: $18.40 Not disclosed
Disclosure

SEC source: 0001193125-26-214890 · ownership.xml · derivative · entry 6

Aggarwal Sumit · CIK 0001854362 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 42,790 shares

Expires 2032-02-06

F4 · shares: On December 1, 2022, the Issuer effected a 1-for-40 reverse stock split. The share count has been adjusted to reflect the reverse stock split.

F5 · price: The reporting person agreed to cancellation of an option granted to him on February 6, 2022 in exchange for a new option having a lower exercise price.

F3 · derivative.exercise_date: The stock option vested and became exercisable over the four-year period commencing February 6, 2022, with one-fourth of the shares of common stock underlying the options vesting on February 6, 2023, and the remainder vesting in twelve equal quarterly installments thereafter. The Board accelerated vesting on the unvested portion in connection with the exercise.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.